These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3090332)
21. [Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT]. Sugimachi K; Okamura T; Furusawa M; Saku M; Noda S; Matsusaka T; Teraoka H; Toda T; Oka N; Inokuchi K Gan To Kagaku Ryoho; 1988 Oct; 15(10):2953-7. PubMed ID: 3140734 [TBL] [Abstract][Full Text] [Related]
22. Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I. Niimoto M; Hattori T; Ito I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M Cancer Immunol Immunother; 1984; 18(1):13-8. PubMed ID: 6435856 [TBL] [Abstract][Full Text] [Related]
23. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer. Kurihara M; Izumi T; Yoshida S; Ohkubo T; Suga S; Kiyohashi A; Yaosaka T; Takahashi H; Ito T; Sasai T Jpn J Cancer Res; 1991 May; 82(5):613-20. PubMed ID: 1905707 [TBL] [Abstract][Full Text] [Related]
24. [Surgery and adjuvant therapy of gastric cancer]. Tamada R Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1555-63. PubMed ID: 3089173 [TBL] [Abstract][Full Text] [Related]
25. [A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)]. Muto T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Nakajima T; Kikuchi K Gan To Kagaku Ryoho; 1984 Sep; 11(9):1863-70. PubMed ID: 6433808 [TBL] [Abstract][Full Text] [Related]
26. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate]. Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondou T; Abe O; Kikuchi K; Tanabe T; Ogawa N Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):799-806. PubMed ID: 2496668 [TBL] [Abstract][Full Text] [Related]
27. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer]. Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Ogawa N Gan To Kagaku Ryoho; 1985 Sep; 12(9):1850-63. PubMed ID: 3929694 [TBL] [Abstract][Full Text] [Related]
28. Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer. Grau JJ; Estapé J; Fuster J; Filella X; Visa J; Terés J; Soler G; Albiol S; García-Valdecasas JC; Grande L; Bombí J; Bordas J; Alcobendas F J Clin Oncol; 1998 Mar; 16(3):1036-9. PubMed ID: 9508188 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection. Maehara Y; Moriguchi S; Sakaguchi Y; Emi Y; Kohnoe S; Tsujitani S; Sugimachi K J Surg Oncol; 1990 Nov; 45(3):169-72. PubMed ID: 2122131 [TBL] [Abstract][Full Text] [Related]
30. [Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study]. Jakesz R; Dittrich C; Funovics J; Hofbauer F; Rainer H; Reiner G; Schemper M; Schiessel R; Starlinger M Wien Klin Wochenschr; 1986 Dec; 98(24):824-30. PubMed ID: 3103336 [TBL] [Abstract][Full Text] [Related]
31. [Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer]. Tanaka T; Oka T; Hashimoto I Gan To Kagaku Ryoho; 1985 Jan; 12(1):125-33. PubMed ID: 3917653 [TBL] [Abstract][Full Text] [Related]
32. Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy. Hattori T; Nakajima T; Nakazato H; Tanabe T; Kikuchi K; Abe O; Kondo T; Taguchi T; Komi N; Sugimachi K Jpn J Surg; 1990 Mar; 20(2):127-36. PubMed ID: 2111414 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies]. Inoue Y; Nasu H; Nakamura J; Arakawa H; Masamune O; Yamada N; Furuya M; Ookubo M; Mukojima T; Koizumi R Gan To Kagaku Ryoho; 1989 Nov; 16(11):3567-72. PubMed ID: 2510604 [TBL] [Abstract][Full Text] [Related]
34. Effects of Levamisole in adjuvant immunochemotherapy for gastric cancer; a prospective randomized controlled study. Hattori T; Niimoto M; Toge T; Oride M; Nakao A; Yoshinaka K Jpn J Surg; 1983 Nov; 13(6):480-5. PubMed ID: 6423870 [TBL] [Abstract][Full Text] [Related]
35. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer]. Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293 [TBL] [Abstract][Full Text] [Related]
36. [A clinical study of vitamin A concerning auxiliary chemotherapies after operation of gastric cancer]. Fujii T; Yokomori T Gan To Kagaku Ryoho; 1991 Feb; 18(2):265-9. PubMed ID: 1899548 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation of postoperative longterm chemotherapy against gastric cancer]. Inokuchi K Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):320-5. PubMed ID: 6349534 [TBL] [Abstract][Full Text] [Related]
38. [A randomized controlled trial comparing short-term MF chemotherapy with MF plus long-term HCFU chemotherapy as an adjuvant to a curative resection of stomach cancer: Mifurol Study Group for Stomach Cancer]. Yamamura Y; Nakazato H; Koike A; Ichihashi H Gan No Rinsho; 1988 Nov; 34(14):1936-42. PubMed ID: 3144615 [TBL] [Abstract][Full Text] [Related]
39. [Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer]. Imaizumi M; Kondo T; Kamei H; Ichihashi H Gan To Kagaku Ryoho; 1984 Jan; 11(1):60-8. PubMed ID: 6421243 [TBL] [Abstract][Full Text] [Related]
40. Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer. Sugimachi K; Maehara Y; Akazawa K; Nomura Y; Eida K; Ogawa M; Konaga E; Tanaka N; Toge T; Dohi K; Noda S; Maeda M; Monden Y Breast Cancer Res Treat; 1999 Jul; 56(2):113-24. PubMed ID: 10573104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]